Antiplatelet Therapy

CHAMPION PHOENIX: Primary Efficacy Outcomes at 48

Hours, MITT

TRITON-TIMI 3813,608 Patients With ACS and Planned PCI Randomized to Prasugrel (60/10) vs

Clopidogrel (300/75)

TRITON-TIMI 38 Bleeding Events: Safety Cohort (N = 13,457)

PLATO: Overall Mortality and CABG-Related Bleeding Rates

TiCAB Study Design

Postoperative Management

Abbreviations

Abbreviations (cont)

References

References (cont)